Bryn Pharma’s Anaphylaxis Treatment Gains $11M in Latest Fundraising Round
Many investors have a great deal of confidence in Bryn Pharma, a Raleigh-based pharmaceutical company that is developing an epinephrine nasal spray to treat anaphylaxis.
To read the full article, visit North Carolina Biotechnology Center.